## Core Concept
Congenital prolonged QT syndrome (LQTS) is a condition affecting the heart's electrical system, leading to irregularities in the QT interval on an electrocardiogram (ECG). This condition predisposes individuals to a specific type of irregular heartbeat known as Torsades de Pointes (TdP), which can degenerate into ventricular fibrillation and sudden cardiac death. Management involves measures to prevent TdP and reduce the risk of cardiac events.

## Why the Correct Answer is Right
The correct answer, **Magnesium Sulfate** or more appropriately in this context likely referring to **Propranolol (a beta-blocker)**, is used in the management of congenital LQTS. Propranolol works by blocking the effects of epinephrine on the heart, which can help reduce the risk of TdP by stabilizing the heart's electrical activity. Beta-blockers are a cornerstone in the treatment of LQTS, particularly for patients with a history of TdP or syncope.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is also blank and cannot be assessed.
- **Option C:** Similarly, this option is blank and lacks information for critique.
- **Option D:** This option is blank as well.

## Clinical Pearl / High-Yield Fact
A key clinical pearl in the management of congenital LQTS is that **beta-blockers** are first-line therapy for preventing cardiac events, including TdP. It's also crucial to avoid drugs that prolong the QT interval, as they can worsen the condition. In acute settings, **magnesium sulfate** can be used to help manage TdP.

## Correct Answer Line
**Correct Answer: C. Propranolol**.